Inhibition of RAD51 by SiRNA and Resveratrol Sensitizes Cancer Stem Cells Derived from HeLa Cell Cultures to Apoptosis

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2018 Apr 24

PMID 29681946

Citations 14

Authors

Graciela Ruiz

Heriberto A Valencia-Gonzalez

Ismael Leon-Galicia

Enrique Garcia-Villa

Alejandro Garcia-Carranca

Patricio Gariglio

Affiliations

Soon will be listed here.

Abstract

Cervical cancer is the second most frequent tumor type in women worldwide with cases developing clinical recurrence, metastasis, and chemoresistance. The cancer stem cells (CSC) may be implicated in tumor resistance to therapy. RESveratrol (RES), a natural compound, is an antioxidant with multiple beneficial activities. We previously determined that the expression of RAD51 is decreased by RES. The aim of our study was to examine molecular mechanism by which CSC from HeLa cultures exhibit chemoresistance. We hypothesized CSC repair more efficiently DNA breaks and that RAD51 plays an important role in this mechanism. We found that CSC, derived from cervical cancer cell lines, overexpress RAD51 and are less sensitive to Etoposide (VP16). We inhibited RAD51 in CSC-enriched cultures using RES or siRNA against RAD51 messenger RNA and observed a decrease in cell viability and induction of apoptosis when treated simultaneously with VP16. In addition, we found that inhibition of RAD51 expression using RES also sensitizes CSC to VP16 treatment. Our results suggest that resveratrol is effective to sensitize cervical CSC because of RAD51 inhibition, targeting high RAD51 expressing CD49f-positive cells, which supports the possible therapeutic application of RES as a novel agent to treat cancer.

Citing Articles

Genetic Variants in (rs2073498), (rs1799889), and (rs12904) Are Associated with Susceptibility in Mexican Patients with Colorectal Cancer: Clinical Associations and Their Analysis In Silico.

Tovar-Jacome C, Juarez-Vazquez C, Gallegos-Arreola M, Garcia-Ortiz J, Marin-Contreras M, Pineda-Razo T Genes (Basel). 2025; 16(2).

PMID: 40004552 PMC: 11855561. DOI: 10.3390/genes16020223.

Targeting the DNA damage response (DDR) of cancer cells with natural compounds derived from and other plants.

Choi S, Shin M, Kim W J Ginseng Res. 2025; 49(1):1-11.

PMID: 39872282 PMC: 11764321. DOI: 10.1016/j.jgr.2024.04.001.

Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer.

Liu W, Wang Y, Xia L, Li J Nutrients. 2024; 16(6).

PMID: 38542707 PMC: 10975298. DOI: 10.3390/nu16060797.

DNA Repair and Therapeutic Strategies in Cancer Stem Cells.

Gillespie M, Ward C, Davies C Cancers (Basel). 2023; 15(6).

PMID: 36980782 PMC: 10047301. DOI: 10.3390/cancers15061897.

The use of African medicinal plants in cancer management.

Gaobotse G, Venkataraman S, Brown P, Masisi K, Kwape T, Nkwe D Front Pharmacol. 2023; 14:1122388.

PMID: 36865913 PMC: 9971233. DOI: 10.3389/fphar.2023.1122388.

References

Carter L, DOrazio J, Pearson K . Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer. 2014; 21(3):R209-25. PMC: 4013237. DOI: 10.1530/ERC-13-0171. View

Seino M, Okada M, Shibuya K, Seino S, Suzuki S, Takeda H . Differential contribution of ROS to resveratrol-induced cell death and loss of self-renewal capacity of ovarian cancer stem cells. Anticancer Res. 2015; 35(1):85-96. View

Hine C, Seluanov A, Gorbunova V . Use of the Rad51 promoter for targeted anti-cancer therapy. Proc Natl Acad Sci U S A. 2008; 105(52):20810-5. PMC: 2634908. DOI: 10.1073/pnas.0807990106. View

Short S, Giampieri S, Worku M, Alcaide-German M, Sioftanos G, Bourne S . Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells. Neuro Oncol. 2011; 13(5):487-99. PMC: 3093331. DOI: 10.1093/neuonc/nor010. View

Kao C, Huang P, Tsai P, Tsai M, Lo J, Lee Y . Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor. Int J Radiat Oncol Biol Phys. 2009; 74(1):219-28. DOI: 10.1016/j.ijrobp.2008.12.035. View

Shankar S, Singh G, Srivastava R . Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci. 2007; 12:4839-54. DOI: 10.2741/2432. View

Ito M, Yamamoto S, Nimura K, Hiraoka K, Tamai K, Kaneda Y . Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin. J Gene Med. 2005; 7(8):1044-52. DOI: 10.1002/jgm.753. View

Pandey P, Okuda H, Watabe M, Pai S, Liu W, Kobayashi A . Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat. 2010; 130(2):387-98. PMC: 3404809. DOI: 10.1007/s10549-010-1300-6. View

Hu L, Cao D, Li Y, He Y, Guo K . Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors. Cancer Biol Ther. 2012; 13(7):516-26. DOI: 10.4161/cbt.19601. View

10.

Kiyohara E, Tamai K, Katayama I, Kaneda Y . The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma. Gene Ther. 2011; 19(7):734-41. DOI: 10.1038/gt.2011.123. View

11.

Ji J, Zheng P . Expression of Sox2 in human cervical carcinogenesis. Hum Pathol. 2010; 41(10):1438-47. DOI: 10.1016/j.humpath.2009.11.021. View

12.

Richardson C . RAD51, genomic stability, and tumorigenesis. Cancer Lett. 2005; 218(2):127-39. DOI: 10.1016/j.canlet.2004.08.009. View

13.

Yang Y, Chang Y, Huang P, Chiou G, Tseng L, Chiou S . Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. J Cell Physiol. 2011; 227(3):976-93. DOI: 10.1002/jcp.22806. View

14.

He S, Yan X . From resveratrol to its derivatives: new sources of natural antioxidant. Curr Med Chem. 2012; 20(8):1005-17. View

15.

Ortiz-Sanchez E, Santiago-Lopez L, Cruz-Dominguez V, Toledo-Guzman M, Hernandez-Cueto D, Muniz-Hernandez S . Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression. Oncotarget. 2016; 7(22):31943-54. PMC: 5077987. DOI: 10.18632/oncotarget.8218. View

16.

Sato A, Okada M, Shibuya K, Watanabe E, Seino S, Suzuki K . Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells. Stem Cell Res. 2013; 11(1):601-10. DOI: 10.1016/j.scr.2013.04.004. View

17.

Hwang J, Kwak D, Lin S, Kim H, Kim Y, Park O . Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway. Ann N Y Acad Sci. 2007; 1095:441-8. DOI: 10.1196/annals.1397.047. View

18.

Shankar S, Nall D, Tang S, Meeker D, Passarini J, Sharma J . Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One. 2011; 6(1):e16530. PMC: 3031576. DOI: 10.1371/journal.pone.0016530. View

19.

Aggarwal B, Takada Y, Oommen O . From chemoprevention to chemotherapy: common targets and common goals. Expert Opin Investig Drugs. 2004; 13(10):1327-38. DOI: 10.1517/13543784.13.10.1327. View

20.

Singh N, McCoy M, Tice R, Schneider E . A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988; 175(1):184-91. DOI: 10.1016/0014-4827(88)90265-0. View